Research & Development Strategy

MTPL Pharma focuses on advanced active ingredient research, process development, and technology innovation.

MTPL Pharma (UAB Mokslinių tyrimų plėtros laboratorija) is a Lithuanian biotechnology company focused on fundamental, applied, and experimental research. The company develops advanced active ingredients, formulation systems, and technology based solutions.

Our work integrates research and development into a single process, from ingredient discovery and formulation design to intellectual property, product strategy, and commercialization. This approach allows us to efficiently translate scientific concepts into scalable, market ready solutions across supplements, cosmetics, and medical purpose products.

Research and Development

Research and development are central to MTPL Pharma. We treat innovation as a practical discipline that guides how we work, where we focus, and how we allocate resources.

Our primary focus is the extraction and optimization of phytoactive compounds, with particular attention to improving both the quality and yield of plant derived active ingredients using nanotechnology. Alongside this, we build the foundation for technology development, patent protection, and future commercialization.

Our goal is to create favorable conditions for technology development, patent protection, and future commercialization.

In product development, we focus on creating clear and scientifically grounded pathways that enable new products and improve existing ones. This includes the development of advanced phytoactive molecular combinations with broader functional and therapeutic potential.

Our Vision

To become a recognized partner in advanced active ingredient research and pharmaceutical process innovation.

Our Mission

To develop scientifically validated, scalable, and safe active ingredient technologies for research institutions and industry partners.

Scientific Collaboration & Expert Network